Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Rev Med Suisse ; 2(72): 1689-90, 1692-5, 2006 Jun 28.
Artículo en Francés | MEDLINE | ID: mdl-16884061

RESUMEN

Cigarette smoking amongst women is a major issue in daily clinical practice and in public health. Tobacco is the cause of gender specific diseases. From a psychosocial point of view, female smokers tend to be emotionally vulnerable and relationship sensitive. The risk of weight gain and depression must be anticipated and assessed throughout the smoking cessation process. Professionals involved in smoking cessation must be aware of these somatic and psychosocial specificities in order to be able to offer efficient smoking cessation treatments. Public health strategies must also be developed worldwide to control the expected dramatic impact of the female tobacco epidemic.


Asunto(s)
Fumar/efectos adversos , Fumar/epidemiología , Mujeres , Femenino , Humanos , Fumar/psicología , Cese del Hábito de Fumar
2.
Rev Med Suisse ; 2(72): 1696-700, 2006 Jun 28.
Artículo en Francés | MEDLINE | ID: mdl-16884062

RESUMEN

Women who smoke underestimate the risks of smoking on their health, especially the impact of the anti-estrogenic and toxic effects of tobacco at the different stages of their life. The risk of female infertility related to tobacco is now well-proven, as is the risk of arterial and venous thrombotic event when tobacco is associated with oral contraception. Many foetal and maternal pathologies are linked to maternal smoking. Regarding post-menopausal women, smoking is associated with an increased osteoporotic and cardio-vascular risk. Doctors are at the first line to advise women and propose them help and assistance in their quit smoking process in a way adapted to their situation.


Asunto(s)
Fumar/efectos adversos , Salud de la Mujer , Femenino , Humanos , Cese del Hábito de Fumar/métodos
3.
J Intern Med ; 250(1): 73-9, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11454145

RESUMEN

BACKGROUND: Hypercalcaemia of malignancy, a relatively frequent phenomenon, seems to be insufficiently recognized and treated. Its symptoms are not specific, but they affect the quality of life. METHODS: A prospective study to analyse the influence of symptoms caused by hypercalcaemia on the decision of the admitting physician, the motivation for treatment, and the effect of the treatment on the given symptoms in hospitalized patients with oncologic disease in progression, where confounding causes of similar symptoms such as cerebral metastasis, radiotherapy, treatment with opioids, etc., were excluded. RESULTS: A total of 71 patients, mean age 65 + 11 years, fulfilled the strict inclusion criteria. About 42% were hospitalized because of symptoms caused by hypercalcaemia, but none of the medical reports mentioned hypercalcaemia as reason for hospitalization. Specific antihypercalcaemic therapy was given to only 37% of patients, and only 25% got an adequate rehydratation. Antihypercalcaemic treatment was guided by the severity of hypercalcaemia (>3.00 mmol L(-1)), not by the symptoms. Polyuria-polydipsia, nausea-vomiting and constipation were correlated with hypercalcaemia. These symptoms, as well as confusion-stupor and bone pains improved significantly when calcaemia was normalized. Patients with calcaemia normalized returned home most frequently (P < 0.03). CONCLUSIONS: Malignant hypercalcaemia remains mostly undiagnosed in medical praxis. Specific treatment occurs in too small fractions of the patients. As the normalization of calcaemia significantly improves the symptoms because of hypercalcaemia and the quality of life, rapid rehydration and specific calcium lowering treatments should be part of palliative measures in all patients with malignant hypercalcaemia.


Asunto(s)
Hipercalcemia/diagnóstico , Hipercalcemia/etiología , Neoplasias/complicaciones , Huesos/metabolismo , Coma/etiología , Confusión/etiología , Estreñimiento/etiología , Difosfonatos/uso terapéutico , Humanos , Hipercalcemia/complicaciones , Hipercalcemia/terapia , Náusea/etiología , Dolor/etiología , Cuidados Paliativos/métodos , Poliuria/etiología , Estudios Prospectivos , Calidad de Vida , Sed , Vómitos/etiología
4.
Schweiz Med Wochenschr ; 126(48): 2082-6, 1996 Nov 30.
Artículo en Francés | MEDLINE | ID: mdl-8992629

RESUMEN

BACKGROUND: Immunization against influenza is recommended for elderly persons in Switzerland, but no national guidelines are currently available regarding immunization of the elderly against pneumococcus and tetanus. In addition, almost no data are available regarding immunization rates of the elderly in the general population. In this study we explored the immunization status for influenza, tetanus and pneumococcus of a selected elderly population admitted to a Swiss rehabilitation facility. POPULATION AND METHODS: The study population (n = 145) were patients admitted to a rehab facility during 3 consecutive winter months. Data on demographics, immunization, previous functional status (BADL, IADL), cognitive (MMSE) and affective status (GDS) were collected upon admission. RESULTS: Subjects' mean age was 79.4 years, 32.4% were male, 42.8% had BADLs dependencies and 81.9% IADLs dependencies. Most patients had normal MMSE and GDS scores. Vaccination rates were 39.3% for influenza, 12.4% for tetanus and only 2.1% for pneumococcus. In univariate analyses, people immunized against influenza were older than those who were not (p = 0.01). This relationship remained in multivariate analyses, controlling for gender, functional, cognitive and affective status. Subjects aged 80 and over were 2.5 times (95% CI 1.2-5.5, p = 0.02) more likely to be immunized against influenza, but were less likely to be immunized against tetanus (OR 0.3, 95% CI 0.1-0.9, p = 0.04). Functional status was not significantly associated with any vaccination status. CONCLUSIONS: Immunization rate for influenza in this selected population is similar to those described in US surveys. The positive association between older age and flu vaccination is surprising and needs further investigation. These results also indicate a need to educate patients and physicians in order to increase vaccination use, especially against pneumococcus.


Asunto(s)
Vacunas Bacterianas , Vacunas contra la Influenza , Streptococcus pneumoniae/inmunología , Toxoide Tetánico , Actividades Cotidianas , Anciano , Anciano de 80 o más Años , Educación Médica Continua , Femenino , Humanos , Masculino , Salud Mental , Educación del Paciente como Asunto , Vacunas Neumococicas , Rehabilitación , Suiza
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...